Semaglutide is an FDA-approved injection prescription weight loss medication that is a derivative of a natural hormone released from your body. Your body typically produces this hormone when you consume carbohydrates and proteins.
Originally developed and approved as a type 2 diabetes medication, Semaglutide can help regulate your blood sugar, slow down your digestion, and communicate with the center of your brain that regulates your appetite.
Semaglutide is also recommended for patients with known cardiovascular disease. A major study found that taking Semaglutide can contribute up to a 20% reduction in cardiovascular death, as well as non-fatal heart attacks and strokes.
Novo Nordisk, the makers of Semaglutide, have discontinued the use of body mass index (BMI) as the only means for patients to qualify for this medication. This means that other important metabolic parameters, such as waist circumference or percent fat mass, are now evaluated to assess eligibility for Semaglutide.
Semaglutide works best in conjunction with adequate high-quality protein consumption and balanced nutrition.
Its main side effects are nausea, indigestion, bloating, diarrhea, or constipation, which go away with time.
Semaglutide may also be combined with other anti-obesity medications. Please note that at this time all anti-obesity medications are not approved for those who are planning to conceive or are pregnant or breastfeeding.